The round in numbers
RoundUS$500,000
Equity25%
Pre-moneyUS$1,500,000
Post-moneyUS$2,000,000
24-month spendUS$453,371
24-month revenueUS$255,684
Monthly revenue, month 24US$31,850
Peak cash usedUS$223,844
Buffer if revenue landsUS$276,156
BreakevenMonth 21
Charts
Monthly revenue vs. spend
Bars: monthly operating cost. Line: projected revenue.
SpendRevenue
Cash used vs. round size
Cumulative loss (spend − revenue). While it stays below the dashed line, the round is enough.
Cumulative cash usedRound
Where does each month go?
Monthly spend by category: the team is the main cost.
Hired teamFoundersInfrastructure and AILegal and toolsMarketing
Use of funds (24 months)
How the full round is allocated, contingency included.
Product and engineering teamUS$87,568 · 17.6%
Sales, marketing and customer successUS$274,500 · 55%
Founders (time dedicated to the project)US$45,535 · 9.1%
Infrastructure and AI computeUS$19,368 · 3.9%
Legal, compliance and toolsUS$26,400 · 5.3%
Contingency (10%)US$45,337 · 9.1%
How it is calculated
- Cost per person = gross monthly salary in MXN × 1.35 (payroll burden) ÷ 18.5 MXN per dollar. E.g. Full-stack developer, MXN 50,000 → US$3,649 per month.
- Founders: the 3 partners spend 10% of their time on this product = US$1,897 per month.
- Infrastructure and AI starts at US$600 per month and grows 3% a month with usage, reaching US$1,014 in month 24.
- Monthly spend = team + founders + infrastructure and AI + legal and tools + marketing. The 24 months add up to US$453,371.
- Round size = gross spend US$453,371 + 10% contingency US$45,337, rounded up to US$25k = US$500,000. Revenue is not netted out: if it does not arrive, the round still covers 24 months.
- Peak cash used = the highest point of cumulative loss (spend − revenue) = US$223,844, in month 20. Buffer = round − peak cash used = US$276,156.
- Equity = round ÷ (pre-money + round) = US$500,000 ÷ US$2,000,000 = 25%. The pre-money is anchored on real comparables (see Valuation).
- Breakeven = first month in which revenue covers spend: month 21.
Revenue estimate
Monthly revenue from US$0 in month 1 to US$31,850 in month 24 (US$382,202 annualized); US$255,684 cumulative over 24 months. Assumptions:
- No revenue in the first 2 months (partner signing and compliance).
- Routed cases: 40/month in month 3, growing 15% monthly: ~750 cases/month by month 24.
- Average coordination fee: US$35 per case attended by a partner.
- Partners with membership: 10 in month 4, +5 per month (US$50/month).
Funded team
Market gross salaries for startups in Mexico; employer cost = salary × 1.35; exchange rate 18.5 MXN/USD.
| Role | Gross salary/month | Allocation | From | Cost US$/month |
|---|
| Full-stack developer | MXN 50,000 | 1 | Month 1 | US$3,649 |
| Customer success / implementation | MXN 35,000 | 1 | Month 1 | US$2,554 |
| Growth / digital marketing | MXN 45,000 | 1 | Month 3 | US$3,284 |
| B2B account executive | MXN 40,000 | 1 | Month 4 | US$2,919 |
| Support / operations | MXN 25,000 | 1 | Month 6 | US$1,824 |
| Founders (10% of their time) | — | — | Month 1 | US$1,897 |
Operating expenses
| Item | US$/month (month 1) |
|---|
| Infrastructure (servers, database, telephony) | US$300 |
| AI compute (LLM, voice, OCR) | US$300 |
| SaaS tools | US$200 |
| Legal, accounting and compliance | US$600 |
| Other (office, travel, insurance) | US$300 |
| Marketing | US$500 |
Infrastructure and AI compute grow 3% a month; everything else stays flat.
Valuation: why this pre-money
Complete product but no revenue or documented cases; below the YC reference.
| Comparable | Actual data | Source |
|---|
| Accolade (US) | Acquired by Transcarent for US$621 M (2025), 1.21x sales | fiercehealthcare.com |
| Garner Health (US) | US$118 M Series D [verify] | secondary comparison |
See month-by-month table
| Month | Revenue | Spend | Net cash flow | Cumulative cash used |
|---|
| Month 1 | US$0 | US$10,300 | −US$10,300 | US$10,300 |
| Month 2 | US$0 | US$10,318 | −US$10,318 | US$20,618 |
| Month 3 | US$1,400 | US$15,120 | −US$13,720 | US$34,338 |
| Month 4 | US$2,110 | US$18,057 | −US$15,947 | US$50,284 |
| Month 5 | US$2,602 | US$18,075 | −US$15,473 | US$65,758 |
| Month 6 | US$3,129 | US$19,917 | −US$16,788 | US$82,545 |
| Month 7 | US$3,699 | US$19,935 | −US$16,236 | US$98,782 |
| Month 8 | US$4,316 | US$19,953 | −US$15,637 | US$114,419 |
| Month 9 | US$4,988 | US$19,971 | −US$14,983 | US$129,402 |
| Month 10 | US$5,724 | US$19,989 | −US$14,265 | US$143,667 |
| Month 11 | US$6,533 | US$20,007 | −US$13,474 | US$157,141 |
| Month 12 | US$7,425 | US$20,025 | −US$12,600 | US$169,741 |
| Month 13 | US$8,414 | US$20,043 | −US$11,629 | US$181,370 |
| Month 14 | US$9,513 | US$20,061 | −US$10,548 | US$191,918 |
| Month 15 | US$10,740 | US$20,079 | −US$9,339 | US$201,257 |
| Month 16 | US$12,114 | US$20,097 | −US$7,983 | US$209,240 |
| Month 17 | US$13,656 | US$20,115 | −US$6,459 | US$215,699 |
| Month 18 | US$15,392 | US$20,133 | −US$4,741 | US$220,440 |
| Month 19 | US$17,351 | US$20,151 | −US$2,800 | US$223,240 |
| Month 20 | US$19,566 | US$20,169 | −US$603 | US$223,844 |
| Month 21 | US$22,076 | US$20,187 | US$1,889 | US$221,955 |
| Month 22 | US$24,924 | US$20,205 | US$4,719 | US$217,236 |
| Month 23 | US$28,163 | US$20,223 | US$7,940 | US$209,296 |
| Month 24 | US$31,850 | US$20,241 | US$11,609 | US$197,686 |
A projection, not a result: the figures depend on the stated assumptions and are not a public offering of securities.
